Stoke Therapeutics, Inc. (STOK) Debt-to-equity % [USD] 2020 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Stoke Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from 2020 to 2024.
  • Stoke Therapeutics, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 40.3 %, a 15% increase year-over-year.
Debt-to-equity, Quarterly (% [USD])
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 40.3 +5.27 +15% Mar 31, 2024
Q4 2023 36.7 +1.81 +5.19% Dec 31, 2023
Q3 2023 35.8 +7.86 +28.1% Sep 30, 2023
Q2 2023 35.2 +14.5 +70.2% Jun 30, 2023
Q1 2023 35 +22.1 +171% Mar 31, 2023
Q4 2022 34.9 +29.5 +545% Dec 31, 2022
Q3 2022 27.9 +23.8 +569% Sep 30, 2022
Q2 2022 20.7 +17.2 +494% Jun 30, 2022
Q1 2022 12.9 +9.5 +279% Mar 31, 2022
Q4 2021 5.41 +1.78 +49% Dec 31, 2021
Q3 2021 4.18 +1.18 +39.3% Sep 30, 2021
Q2 2021 3.49 +0.88 +33.8% Jun 30, 2021
Q1 2021 3.41 +1.13 +49.7% Mar 31, 2021
Q4 2020 3.63 Dec 31, 2020
Q3 2020 3 Sep 30, 2020
Q2 2020 2.6 Jun 30, 2020
Q1 2020 2.28 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.